News

Two Calls for Expression of Interest for positions in Life Sciences at ERCEA

Published on | 2 years ago

Programmes ERC Health

The European Research Council Executive Agency (ERCEA) currently has two Calls for Expression of Interest open for positions in the Life Sciences domain:

  • Research Programme Agents (AD6) in Life Sciences

More information in the Call for Expression of Interest. Those interested should send their completed application form to ERC-SELECTION@ec.europa.eu by 31 January 2024 at 12:00 (midday) Brussels time.

  • Research Programme Expert (Seconded National Expert) in Life Sciences

More information in the Call for Expression of Interest. Applicants must send their completed applications (CV, Application Form, current contract and declaration on status of employment) to the Permanent Representations, the EFTA Secretariat or the Permanent Delegation of Turkey.

The Permanent Representations, the EFTA Secretariat and the Permanent Delegation of Turkey, must forward the applications to: ERC-SELECTION@ec.europa.eu by 15 February 2024 at 12:00 (midday) Brussels time.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1780 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.